Investigating intestinal inflammation in DSS-induced model of IBD.
Kim JJ, Shajib MS, Manocha MM, Khan WI.
J Vis Exp. 2012 Feb 1;(60):3678. doi: 10.3791/3678.
Exploring the mechanism of Xingpi Capsule in diarrhea predominant-irritable bowel syndrome treatment based on multiomics technology.
Qian W, Li W, Chen X, Cui L, Liu X, Yao J, Wang X, Liu Y, Li C, Wang Y, Wang W.
Phytomedicine. 2023 Mar;111:154653. doi: 10.1016/j.phymed.2023.154653. Epub 2023 Jan 11.
[Ulcerative colitis].
Roose L, D'cunja J, Biedermann L.
Praxis (Bern 1994). 2016 May 25;105(11):607-15. doi: 10.1024/1661-8157/a002358.
Infectious Colitis.
Azer SA, Tuma F.
2022 Sep 26. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–.
Microbiome Structure and Mucosal Morphology of Jejunum Appendix and Colon of Rats in Health and Dysbiosis.
Shao C, Song X, Wang L, Zhang H, Liu Y, Wang C, Chen S, Ren B, Wen S, Xiao J, Tang L.
Curr Microbiol. 2023 Mar 6;80(4):127. doi: 10.1007/s00284-023-03224-0.
Octreotide-Associated Neutropenia.
Tse SS, Kish T.
Pharmacotherapy. 2017 Jun;37(6):e32-e37. doi: 10.1002/phar.1942.
Multi-responsive starch-based nanocapsules for colon-targeting delivery of peptides: In vitro and in vivo evaluation.
Hou H, Chi C, Wang T, He Y, Chen L, Li X.
Int J Biol Macromol. 2023 Jul 1;242(Pt 3):124953. doi: 10.1016/j.ijbiomac.2023.124953. Epub 2023 May 19.
Yinlai Decoction Protects Microstructure of Colon and Regulates Serum Level of D-Lactic Acid in Pneumonia Mice Fed with High-Calorie and High-Protein Diet.
Wang YH, Yu H, Liu TG, Kong TC, Zheng ZA, Wan YX, Bai C, Hao Y, Mao YQ, Wu J, Xu JN, Cui LJ, Wang YH, Shan YR, Shao YJ, Gu XH.
Chin J Integr Med. 2023 Aug;29(8):714-720. doi: 10.1007/s11655-023-3697-x. Epub 2023 Jun 21.
Development of the mucosal vascular system in the distal colon of the fetal mouse.
Ito T, Ohi S, Tachibana T, Takahara M, Hirabayashi T, Ishikawa H, Kusakabe M, Hashimoto H.
Anat Rec (Hoboken). 2008 Jan;291(1):65-73. doi: 10.1002/ar.20621.
Modulation of Naturally Occurring Linear Dipeptide Chirality to Reduce the Affinity for Oligopeptide Transporter 1 and Increase Intestinal Stability for an Enhanced Colon-Targeting Effect in the Treatment of Inflammatory Bowel Disease: An Application of trans-4-l-Hydroxyprolyl-l-serine.
Jiang Q, Xu Q, Wang Y, Li P, Zhang Y, Wang Y, Sun J, Zhang T, He Z.
J Med Chem. 2022 Mar 24;65(6):4565-4577. doi: 10.1021/acs.jmedchem.1c01276. Epub 2021 Nov 29.
